Pomalidomide (POM), bortezomib, and low-dose dexamethasone (PVd) vs bortezomib and low-dose dexamethasone (Vd) in lenalidomide (LEN)-exposed patients (pts) with relapsed or refractory multiple myeloma (RRMM): Phase 3 OPTIMISMM trial.

被引：14

作者：

Richardson, Paul G.

Rocafiguera, Albert Oriol

Beksac, Meral

Liberati, Anna Marina

Galli, Monica

Schjesvold, Fredrik

Lindsay, Jindriska

Weisel, Katja

White, Darell

Facon, Thierry

San-Miguel, Jesus

Sunami, Kazutaka

O'Gorman, Peter

Sonneveld, Pieter

Yu, Xin

Doerr, Thomas

Bensmaine, Amine

Zaki, Mohamed H.

Anderson, Kenneth Carl

Dimopoulos, Meletios A.

机构：

[1] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[2] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain

[3] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain

[4] Ankara Univ, Cebeci Yerleskesi, Dikimevi, Ankara, Turkey

[5] Univ Perugia, Terni, Perugia, Italy

[6] Osped Riuniti Bergamo, Osped Papa Giovanni XXIII, Ematologia, Bergamo, Italy

[7] Univ Oslo, Rikshosp, Postboks, Oslo, Norway

[8] East Kent Hosp Univ NHS Fdn Trust, Canterbury, Kent, England

[9] Univ Tubingen, Dept Hematol, Tubingen, Germany

[10] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada

[11] Hop Claude Huriez, Lille, France

[12] Clin Univ Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain

[13] Natl Hosp Org Okayama Med Ctr, Kitaku, Japan

[14] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Dublin, Ireland

[15] Erasmus MC Canc Inst, Rotterdam, Netherlands

[16] Celgene Corp, Summit, NJ USA

[17] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.8001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8001

引用

页数：2

共 50 条

[11] Pomalidomide, bortezomib, and dexamethasone (PVd) in lenalidomide (LEN)-pretreated relapsed refractory multiple myeloma: Subanalysis of patients with renal impairment in OPTIMISMM.
Schjesvold, Fredrik
Dimopoulos, Meletios A.
Beksac, Meral
Oriol, Albert
Lindsay, Jindriska
Liberati, Anna Marina
Galli, Monica
Robak, Pawel
Weisel, Katja
Larocca, Alessandra
Yagci, Munci
Vural, Filiz
Anderson, Larry D., Jr.
Kanate, Abraham Sebastian
Mendez, Eva Casal
Jiang, Ruiyun
Srinivasan, Shankar
Grote, Lara
Biyukov, Tsvetan Nikolov
Richardson, Paul G.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[12] MM-007: A phase 3 trial comparing the efficacy and safety of pomalidomide (POM), bortezomib (BORT), and low-dose dexamethasone (LoDEX [PVD]) versus BORT and LoDEX (VD) in subjects with relapsed or refractory multiple myeloma (RRMM).
Richardson, Paul G.
Bensmaine, Amine
Doerr, Thomas
Wang, Jianming
Zaki, Mohamed H.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[13] Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Bahlis, Nizar J.
Sutherland, Heather
White, Darrell
Sebag, Michael
Lentzsch, Suzanne
Kotb, Rami
Venner, Christopher P.
Gasparetto, Cristina
Del Col, Aldo
Neri, Paola
Reece, Donna
Kauffman, Michael
Shacham, Sharon
Unger, T. J.
Jeha, Jacqueline
Saint-Martin, Jean-Richard
Shah, Jatin
Chen, Christine
BLOOD, 2018, 132 (24) : 2546 - 2554
[14] POMALIDOMIDE, BORTEZOMIB, AND LOW-DOSE DEXAMETHASONE (PVD) IN LENALIDOMIDE-REFRACTORY AND PROTEASOME INHIBITOR-EXPOSED MYELOMA: THE MM-005 TRIAL
Richardson, P.
Hofmeister, C.
Raje, N.
Siegel, D.
Lonial, S.
Laubach, J.
Efebera, Y.
Vesole, D. H.
Nooka, A. K.
Rosenblatt, J.
Zaki, M. H.
Hua, Y.
Li, Y.
Shah, S.
Wang, J.
Anderson, K. C.
HAEMATOLOGICA, 2014, 99 : 104 - 104
[15] Correction: Pomalidomide, bortezomib, and low-dose dexamethasone in lenalidomide-refractory and proteasome inhibitor-exposed myeloma
P. G. Richardson
C. C. Hofmeister
N. S. Raje
D. S. Siegel
S. Lonial
J. Laubach
Y. A. Efebera
D. H. Vesole
A. K. Nooka
J. Rosenblatt
D. Doss
M. H. Zaki
A. Bensmaine
J. Herring
Y. Li
L. Watkins
M. S. Chen
K. C. Anderson
Leukemia, 2018, 32 : 2305 - 2305
[16] Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed Lenalidomide Refractory Multiple Myeloma (MM)
Lacy, Martha Q.
LaPlant, Betsy R.
Laumann, Kristina M.
Kumar, Shaji
Gertz, Morie A.
Hayman, Suzanne R.
Buadi, Francis
Dispenzieri, Angela
Lust, John A.
Kapoor, Prashant
Leung, Nelson
Russell, Stephen J.
Dingli, David
Gonsalves, Wilson I.
Fonseca, Rafael
Bergsagel, P. Leif
Roy, Vivek
Sher, Taimur
Ailawadhi, Sikander
Chanan-Khan, Asher
Stewart, A. Keith
Reeder, Craig B.
Rajkumar, S. Vincent
Mikhael, Joseph R.
BLOOD, 2014, 124 (21)
[17] Bortezomib, low-dose intravenous melphalan, and dexamethasone for patients with relapsed multiple myeloma
Popat, Rakesh
Oakervee, Heather
Williams, Catherine
Cook, Mark
Craddock, Charles
Basu, Supratik
Singer, Charles
Harding, Stephen
Foot, Nicola
Hallam, Simon
Odeh, Liz
Joel, Simon
Cavenagh, Jamie
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 144 (06) : 887 - 894
[18] Phase 3 randomised study of daratumumab, bortezomib and dexamethasone (DVd) vs bortezomib and dexamethasone (Vd) in patients (pts) with relapsed or refractory multiple myeloma (RRMM): CASTOR
Weisel, K.
Palumbo, A.
Chanan-Khan, A.
Nooka, A. K.
Spicka, I.
Masszi, T.
Beksac, M.
Hungria, V.
Munder, M.
Mateos, M-V.
Mark, T. M.
Spencer, A.
Qi, M.
Schecter, J.
Amin, H.
Qin, X.
Deraedt, W.
Ahmadi, T.
Sonneveld, P.
ANNALS OF ONCOLOGY, 2016, 27
[19] Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
Badros, Ashraf
Hyjek, Elizabeth
Ma, Ning
Lesokhin, Alexander
Dogan, Ahmet
Rapoport, Aaron P.
Kocoglu, Mehmet
Lederer, Emily
Philip, Sunita
Milliron, Todd
Dell, Cameron
Goloubeva, Olga
Singh, Zeba
BLOOD, 2017, 130 (10) : 1189 - 1197
[20] Pomalidomide (POM) with Low-Dose Dexamethasone (LoDex) in Patients (Pts) with Relapsed and Refractory Multiple Myeloma Who Have Received Prior Therapy with Lenalidomide (LEN) and Bortezomib (BORT): Updated Phase 2 Results and Age Subgroup Analysis
Jagannath, Sundar
Hofmeister, Craig C.
Siegel, David S.
Vij, Ravi
Lonial, Sagar
Anderson, Kenneth C.
Chen, Min
Zaki, Mohamed
Richardson, Paul G.
BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →